TipRanks
Go Ultimate55% OFF

Cytek Biosciences (CTKB) Balance Sheet

Cytek Biosciences Balance Sheet

Cytek Biosciences's total assets for Q2 2026 were $446.93M, a decrease of 0.49% from the previous quarter. CTKB total liabilities were $124.98M for the fiscal quarter, a 2.89% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 461.54M$ 499.50M$ 494.46M$ 519.48M$ 463.31M
$ 119.80M$ 103.76M$ 101.39M$ 93.93M$ 57.92M
$ 341.74M$ 395.74M$ 393.06M$ 425.55M$ 405.38M

Currency in USD

Cytek Biosciences Debt to Assets

0200M400M600M0 %60 %120 %180 %LiabilitiesDebt to Assets2019202020212022202320242025AssetsLiabilitiesDebt to Assets